These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2166253)

  • 1. [A comparative study of the effects of lisinopril and quinapril administered once a day in essential hypertension].
    De Cesaris R; Ranieri G; Andriani A; Chiarappa R
    Minerva Med; 1990; 81(7-8):541-6. PubMed ID: 2166253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative study of the efficacy of lisinopril versus quinapril in controlling light to moderate arterial hypertension. A follow-up with ABPM].
    Motero Carrasco J
    Rev Esp Cardiol; 1995 Nov; 48(11):746-53. PubMed ID: 8532944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinapril versus enalapril in the treatment of mild-to-moderate essential hypertension.
    Sánchez S; Luna A; Orozco R; Velasco G
    Clin Ther; 1991; 13(5):651-5. PubMed ID: 1799922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conversion from oral ACE inhibitor to intravenous quinaprilat administration in mild to moderate essential hypertension].
    Schmidt BM; Smilde J; Oldenbroek C; Wehling M
    Med Klin (Munich); 1998 Dec; 93(12):701-6. PubMed ID: 10024837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the clinical need for short-term conversion from oral to parenteral angiotensin converting enzyme inhibitor therapy in hypertensive patients. A quinapril to quinaprilat placebo-controlled model.
    Whelton A; McCormick L; Wombolt D; Goldstein R; Canter D
    Eur Heart J; 1997 Jan; 18(1):140-7. PubMed ID: 9049526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Study Group of Quinapril in Arterial Hypertension. The Steering Committee].
    Ambrosioni E; Brusca A; Caponnetto S; Condorelli M; Corea L; Dal Palù C; Fogari R; Mameli P; Mancia G; Neri Serneri GG
    Minerva Cardioangiol; 1992 Mar; 40(3):85-96. PubMed ID: 1630680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the efficacy and safety of quinapril with that of enalapril in the treatment of mild to moderate essential hypertension.
    Taylor SH
    Angiology; 1989 Apr; 40(4 Pt 2):382-8. PubMed ID: 2539763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinapril versus atenolol in the treatment of mild to moderate essential hypertension.
    Bahena JH; Estrella ME; Muñoz M
    Clin Ther; 1992; 14(4):527-36. PubMed ID: 1525787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and efficacy of quinapril in the treatment of mild to moderate essential hypertension.
    Frishman WH
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII19-25. PubMed ID: 2189617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lisinopril dose-response relationship in essential hypertension.
    Gomez HJ; Cirillo VJ; Sromovsky JA; Otterbein ES; Shaw WC; Rush JE; Chrysant SG; Gradman AH; Leon AS; MacCarthy EP
    Br J Clin Pharmacol; 1989 Oct; 28(4):415-20. PubMed ID: 2556172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of mild to moderate hypertension with ACE inhibitors.
    Taylor SH
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S24-8. PubMed ID: 1691403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ; Posvar E
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can an angiotensin-converting enzyme inhibitor with a short half-life effectively lower blood pressure for 24 hours?
    Palatini P
    Am Heart J; 1992 May; 123(5):1421-5. PubMed ID: 1575169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril.
    Frishman WH; Greenberg S
    Am J Hypertens; 1991 Oct; 4(10 Pt 1):827-31. PubMed ID: 1747216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor.
    Gupta RK; Kjeldsen SE; Motley E; Weder AB; Zweifler AJ; Julius S
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):13-9. PubMed ID: 1708046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The response to the first dose of an angiotensin converting enzyme inhibitor in uncomplicated hypertension--a placebo controlled study utilising ambulatory blood pressure recording.
    MacFadyen RJ; Bainbridge AD; Lees KR; Reid JL
    Br J Clin Pharmacol; 1991 Sep; 32(3):393-8. PubMed ID: 1777377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension.
    Lenz T; Schulte KL; Wagner B; Lilienthal J; Gotzen R
    Eur Heart J; 1994 Jul; 15(7):940-6. PubMed ID: 7925516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lisinopril: dose-peak effect relationship in essential hypertension.
    Cirillo VJ; Gomez HJ; Salonen J; Salonen R; Rissanen V; Bolognese JA; Nyberg R; Kristianson K
    Br J Clin Pharmacol; 1988 May; 25(5):533-8. PubMed ID: 2841960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enalapril and lisinopril in the treatment of mild to moderate essential hypertension.
    Espinel CH; Williams JL; Coughlin SS
    Clin Ther; 1990; 12(2):181-90. PubMed ID: 2162258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring.
    Lacourcière Y; Lefebvre J; Provencher P; Poirier L
    Br J Clin Pharmacol; 1993 Feb; 35(2):121-7. PubMed ID: 8443029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.